Torrent Pharma Q3 net profit up 2 pc at Rs 251 crore
New Delhi: Drug firm Torrent Pharmaceuticals on Monday reported a 2.03 percent rise in its consolidated net profit to Rs 251 crore for the quarter ended December 31, 2019. The company had posted a net profit of Rs 246 crore for the corresponding period previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Consolidated revenue from operations of the company stood at Rs 1,966 crore for the quarter under consideration. It was Rs 2,051 crore for the same period a year ago.
The company's board has approved the re-appointment of Samir Mehta as Executive Chairman of the company for the period of 5 years effective from April 1, 2020, the filing said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd